Skip to Main Content

Paper Details

A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors.
Clin Cancer Res
99
2017
Author NameAffiliation
Joaquin MateoThe Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
Rakesh Kumar
Sunil SharmaUniversity of Utah Huntsman Cancer Institute
Johann S de BonoThe Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
  • 1 - 4

Datasets

Release 1.2